© Reuters. Traders look at financial information on computer screens on the IG Index trading floor(Reuters) – London’s edged higher on Tuesday with tool hire firm Ashtead (LON:) gaining after an upbeat earnings report and miners boosted by a rise in prices driven by expectations of a global shortfall in production.
The miner-heavy main index was up 0.1% while the midcap index lost 0.2% by 0708 GMT.
Ashtead rose nearly 3%, topping the FTSE 100 leader-board, while miners were up 1% as a key mine in Chile halved output due to a strike.
Drugmaker AstraZeneca was the biggest boost to the FTSE 100 with a 1.1% rise after its cancer medicine Lynparza was approved as a first-line maintenance treatment for a type of advanced ovarian cancer by the European Commission. Rival GlaxoSmithKline also climbed.
Market focus is gradually shifting to a two-day meeting of the U.S. Federal Reserve, with market pricing showing investors expect Wednesday’s policy statement to open the way to a cut in interest rates by the central bank next month.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
